For pediatric* and adult patients with primary humoral immunodeficiency

Proven. Personalized. Leader.

Hizentra PI branding image
Proven icon

Proven: Efficacy & Tolerability

Review study results


Personalized icon

Personalized: Therapeutic Options

Explore individualized therapy


Leader icon

Leader: The #1 Ig Prescribed for PI4

Learn about IgIQ support

*Age 2 and older.

Hizentra is indicated for the treatment of primary immune deficiency (PI) in adults and pediatric patients 2 years and older.

Introducing the newest innovation in Ig

Hizentra is the first and only Ig available in prefilled syringes

Do your PI patients have challenges with their Ig therapy?

Consider Hizentra for patients with PI who:

Hizentra Patient: Marie

Have venous
access issues

Hizentra Patient: Ian

Experience IVIg-related systemic ARs

Clinical Challenges

Hizentra Patient: Sara

Want more freedom
and flexibility

Hizentra Patient: Anthony

Find IVIg infusions inconvenient

Lifestyle Burdens

Important information for healthcare professionals

Below are areas you may find especially helpful when providing Hizentra to your patients.

acuity
You are now leaving the current website.

Do you want to continue?

No Yes